Stockreport

Independent Researchers Find Genprex’s TUSC2 Prevents Tumor Growth in Triple-Negative Breast Cancer

Genprex, Inc.  (GNPX) 
Last genprex, inc. earnings: 11/14 12:08 pm Check Earnings Report
PDF A direct target of miR-138, TUSC2 mimics miR-138 knockdown AUSTIN, Texas & CAMBRIDGE, Mass.--(BUSINESS WIRE)--Genprex, Inc. (NASDAQ: GNPX), a clinical-stage gene ther [Read more]